| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/26/2008 | CN100376245C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348306 Peptide with a sequence selected from the group consisting of Ser-Leu-Ile-Gly-Arg-Leu-NH2, and trans-cynnamoyl-Leu-Ile-Gly-Arg-Leu-ornithine-NH2 combined with amastatins for activation of protease activated receptor-2; eye drop solution for contact lenses |
| 03/25/2008 | US7348155 Method for identifying compounds for treating aging processes in the coronary circulatory system |
| 03/25/2008 | US7348015 Antigen modified cancer cell vaccines for cancer therapy |
| 03/25/2008 | US7348003 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
| 03/25/2008 | US7348000 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 03/25/2008 | US7347996 Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | US7347199 Pressurised metered dose inhalers (MDI) |
| 03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
| 03/25/2008 | CA2327522C Incorporation of active substances in carrier matrixes |
| 03/25/2008 | CA2291796C Therapeutically active compositions |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2228281C Use of l-carnitine and acyl l-carnitines for lowering ceramide levels |
| 03/20/2008 | WO2008034087A2 Treating schizophrenia with combinations of levodopa and an antipsychotic agent |
| 03/20/2008 | WO2008033851A2 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile |
| 03/20/2008 | WO2008033754A2 Xanthine derivatives in methods and compositions for the treatment of vascular depression |
| 03/20/2008 | WO2008033460A2 Treating pain, diabetes, and lipid metabolism disorders |
| 03/20/2008 | WO2008033299A2 Use of n-containing spirocompounds for the enhancement of cognitive function |
| 03/20/2008 | WO2008033155A1 Kits for prevention and treatment of rhinitis |
| 03/20/2008 | WO2008032876A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 03/20/2008 | WO2008032814A1 Aspirin-containing pharmaceutical agent |
| 03/20/2008 | WO2008032696A1 Preventive or therapeutic agent for respiratory disease |
| 03/20/2008 | WO2008032450A1 Prophylactic and/or therapeutic agent for fatty liver |
| 03/20/2008 | WO2008032073A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 03/20/2008 | WO2008031831A2 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| 03/20/2008 | WO2008031820A2 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors |
| 03/20/2008 | WO2008031817A2 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 03/20/2008 | WO2008010223A3 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 03/20/2008 | WO2008009866A3 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor |
| 03/20/2008 | WO2008003667A3 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 03/20/2008 | WO2007149861A3 Soft tissue repair and regeneration using stem cell products |
| 03/20/2008 | WO2007136696A3 Use of substituted azetidinone compounds with cetp inhibitors for the treatment of sitosterolemia |
| 03/20/2008 | WO2007136250A3 A pharmaceutical composition suitable for the treatment of cancer and method of preparing said pharmaceutical composition |
| 03/20/2008 | WO2007064755A3 Treatment of xerostomia with a sulfur-containing antioxidant |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070938 HMG-CoA reductase inhibitor and pyridoxine, pyridoxal, or pyridoxamine; combination therapy; pravastatin, simvastatin, atorvastatin |
| 03/20/2008 | US20080070908 Compositions including antibiotics and methods for using same |
| 03/20/2008 | US20080070886 Anti-cancer combinations |
| 03/20/2008 | US20080070878 Foaming composition for washing and treating hair and/or scalp based on an active principle |
| 03/20/2008 | US20080070851 Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with immunomodulating activity |
| 03/20/2008 | US20080070849 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 03/20/2008 | US20080070848 Anti-cancer combinations |
| 03/20/2008 | US20080070847 Administering 5,6-dimethylxanthenone-4-acetic acid and and administering a compound selected from platinum compounds, vinca alkaloids, alkylating agents, anthracyclines, topoisomerase I inhibitors, antimetabolites and topoisomerase II inhibitors for therapy of cancer |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069900 Combination chemotherapy compositions and methods |
| 03/20/2008 | US20080069899 In mixture with drug that prevents Dna reproduction |
| 03/20/2008 | US20080069882 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere |
| 03/20/2008 | US20080069881 Abuse-resistant controlled-release opioid dosage form |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069825 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
| 03/20/2008 | US20080069801 Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| 03/20/2008 | US20080069773 Novel Sodium Channel |
| 03/20/2008 | DE102006040278A1 Treatment of Charles-Bonnet syndrome, involves administration of serotonin reuptake inhibitor, e.g. venlafaxine or citalopram, to cause rapid and permanent eradication of hallucinations |
| 03/20/2008 | CA2663501A1 Treating pain, diabetes, and disorders of lipid metabolism |
| 03/20/2008 | CA2662432A1 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors |
| 03/20/2008 | CA2662115A1 Methods for enhancing cognitive function |
| 03/20/2008 | CA2659070A1 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 03/19/2008 | EP1900827A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia |
| 03/19/2008 | EP1900378A1 Pharmaceutical compositions for the treatment of fungal infections |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |
| 03/19/2008 | EP1900374A1 Angiogenetic agent containing adrenomedulin as the active ingredient |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1900363A1 Therapeutic agent for pain |
| 03/19/2008 | EP1900362A2 Alfa-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1898953A1 Quadraphasic continuous graduated estrogen contraceptive |
| 03/19/2008 | EP1898952A2 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives) |
| 03/19/2008 | EP1898951A1 Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker |
| 03/19/2008 | EP1898930A2 Treatment of inflammatory conditions |
| 03/19/2008 | EP1898923A1 Aromatase inhibitors for emergency contraception |
| 03/19/2008 | EP1898849A2 New regimens for controlled drug delivery devices for contraception |
| 03/19/2008 | EP1711174B1 Adjuvant compositions |
| 03/19/2008 | EP1682122B1 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 03/19/2008 | EP1581210B1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1469848B1 Sedative non-benzodiazepine formulations |
| 03/19/2008 | EP1453487B1 Pharmaceutical dosage form with multiple coatings |
| 03/19/2008 | EP1429792B1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 03/19/2008 | EP1429725B1 Ophthalmic depot formulations for periocular or subconjunctival administration |
| 03/19/2008 | EP1428880B1 Kidney-specific urate transporter and gene thereof |
| 03/19/2008 | EP1423103A4 Compositions and methods for modulation of darpp-32 phosphorylation |
| 03/19/2008 | EP1392271B1 Swallow tablet comprising paracetamol |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1280604B1 Media milling |
| 03/19/2008 | EP1200137B1 Agent for occluding blood vessels |
| 03/19/2008 | EP1085877B1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 03/19/2008 | EP0971735B1 Methods and compositions for treating inflammatory bowel disease |
| 03/19/2008 | CN101146825A A molecule and chimeric molecules thereof |
| 03/19/2008 | CN101146787A Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia |
| 03/19/2008 | CN101146544A Use of lactobacillus rhamnosus gg for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |